Skip to main content
. 2008 Sep 24;2(9):e306. doi: 10.1371/journal.pntd.0000306

Table 4. Clinical activity, infection (Amplicor) and genotypes by village and timepoint.

BASELINE 2 MONTHS
Village Examined TF/TI CT+ Genotypes Examined TF/TI CT+ Genotypes
1 142 25 20 A2(17) A5(1) 145 21 19 A2(11) A5(1)
2 97 2 0 - 97 2 2 A2(2)
3 115 18 41 A1(10) A2(19) A3(2) A4(1) 105 16 55 A1(5) A2 (45)
4 255 14 8 A2(5) 277 9 0 None
5 107 6 0 - 126 10 0 None
6 39 6 2 A2(1) B2(1) 37 1 0 None
7 86 0 1 - 83 0 0 None
8 83 3 1 - 77 6 0 None
9 23 0 0 - 21 1 0 None
10 60 4 0 - 57 2 0 None
11 97 5 0 - 93 1 0 None
12 103 14 0 - 98 5 0 None
13 53 0 0 - 64 1 0 None
14 58 6 22 A2(14) A6(1) A8(1) B1(1) B2(2) 64 4 0 None

For each village, ‘Examined’ is the number of people examined ‘TF/TI’ is the number of individuals (all ages) with active trachoma, and ‘CT+’ the number of those whose ocular swabs tested positive by Amplicor. The numbers bracketed after the genotype indicate the number of times it appeared: A2 (14) denotes 14 samples contained genotype A2.